The symptoms and signs of toxicity especially looked for in our investigation were vertigo, spontaneous nystagmus, past-pointing, and changes in caloric and galvanic reactions.
Vertigo.-A total of 76 patients were seen, of whom 10 were treated by intermittent dosage of 2 grammes in alternate weeks or months.
Of 66 treated continuously 21 had giddiness divided as follows: On comparing the 2 grammes and 1 gramme in day groups it is evident that patients receiving 2 grammes per day were almost four times more likely to become giddy than those on 1 gramme a day.
The giddiness was present continuously and very severely in 2 patients, both of whom were over 45 years of age and both were members of the medical profession.
In the others the vertigo was complained of after sudden movements such as turning in bed when they felt as if they continued to turn, or on sitting up in bed they felt the process continuing. This usually disappeared in a minute or so.
No past-pointing was noted in any of these patients complaining of giddiness with or without nystagmus. In those with slight giddiness the symptoms lasted less than four weeks, while those with more severe vertigo it lasted longer than four weeks. Thus, if the giddiness experienced is slight in amount, recovery in a short time can be expected, whilst if severe giddiness occurs there may be considerable delay in recovery.
Time of onset of vertigo.-In 16 cases having 2 grammes daily, the mean day of onset of vertigo was the twenty-second with a standard deviation of seven days either way.
With 1 gramme daily (7 cases) the mean day of onset was the forty-fifth, with a much wider standard deviation of twenty-four days. This wide deviation is probably due to the small numbers employed, even so the difference observed is statistically significant. Nausea was less frequently experienced on the 1 gramme a day group than on those taking 2 grammes daily, but the time of onset of the nausea does not show the same relationship to the size of the dose as does giddiness.
Nystagmus.-In 21 patients a first degree spontaneous nystagmus was seen, i.e. nystagmus occurred on looking laterally. In the majority of cases it was present on looking to the right and to the left. This suggests a bilateral stimulation of the vestibulo-oculomotor pathway. Relationship to giddiness.-Of 23 patients who complained of giddiness at some time, nystagmus was detected in 17 at some point during the period of observation.
Of 51 who experienced no giddiness, 8 had nystagmus. Time of onset.-There was no difference in the time of onset of nystagmus in the two dosage groups but 13 out of 21 showed nystagmus during the first month.
Another ocular manifestation of toxicity was the inability to focus the eyes quickly on to a distant object after looking at a near one. For a short time the distant object appeared to shimmer or vibrate. This is probably due to a very fine nystagmus on attempting to accommodate.
Caloric tests.-In many cases it was impossible to obtain a month by month picture of the changes in the caloric reactions particularly in the 1 gramme group. In some cases the patients were too ill, were transferred to sanatoria or underwent surgical operations. However, where possible an assessment of the change in caloric responses was made at the end of the third month and after completion of treatment, which in every case exceeded four months.
The following figures give some idea of the changes which take place in the caloric reactions: Group C consisted of 10 patients receiving 2 grammes per day intermittently on alternate weeks or months, in an attempt to delay the development of a streptomycin resistance. It was impossible to assess 6 of these but in 2 cases the caloric reactions remained unchanged and in 2 they became absent.
The paucity of numbers in the 1 gramme per day group makes it difficult to draw any definite conclusions, but it appears that 1 gramme per day given over a prolonged period (up to eight months) is quite as liable to produce definite vestibular disturbance as 2 grammes per day given for a shorter period. Discussion has centred around the site of the lesion and whether there is any possibility of recovery from the vestibular damage caused.
Compensation occurs readily in young subjects. Our patients had an average age of 25 years.
UJnsteadiness is felt only when walking in total darkness or with the eyes shut. Patients with less complete compensation have difficulty in performing sudden changes of posture.
It was possible to re-examine 8 patients twelve months or more after cessation of streptomycin therapy. All these had previously lost their caloric reactions to water at 300, 440 and 210 for one minute. In 3 of these cases there was no evidence of recovery but in 2 of these galvanic stimulation produced no response. In 4 cases it was possible to obtain a reaction to the test with water at 210 for 1 minute.
One patient who complained of vertigo but no nystagmoid response to cold 210 caloric stimulation in October 1948, on retesting three months later gave a response to water at 30°and 44°. This was two months after cessation of streptomycin. On retesting seventeen months later she gave normal caloric responses.
These cases show that some recovery is possible after severe depression of labyrinthine function.
Site of lesion.-No definite conclusion has yet been reached on this point. Clinically the signs and symptoms are not typical of either a peripheral or of a central lesion. Histological changes have been shown to occur in the medial longitudinal bundle, in Deiter's nucleus and in the cupole of the semicircular canals. Such evidence is mainly based on experimental studies in animals given large doses of streptomycin. Further pathological evidence on the human labyrinth is needed before a definite statement can be given.
Miss M. R. Dix said that about a year ago Mr. Hallpike, Mr. Harrison and herself had had the opportunity of carrying out the galvanic test at Queen Square on a number of streptomycin-treated patients, with very different results (Brain (1949) 72, 241) .
The point of their enquiry was rather a different one. They were interested in Ohm's theory that optokinetic nystagmus and vestibular nystagmus both depended upon the vestibular nuclei. Now the bulk of the published evidence available showed that streptomycin exerted its toxic effect upon the vestibular system, including abolition of the caloric responses, by destroying the vestibular nuclei. In their cases the caloric responses were certainly found to be grossly reduced, but the optokinetic responses were quite normal.
From this they argued that optokinetic nystagmus does not depend upon the vestibular nuclei. But, in addition, considerable reduction in the galvanic responses was found. This accorded with the general notion of a lesion of the vestibular nuclei but it was contrary to and not in accordance with Mr. Thomas' findings.
It was realized that the technique by which this test was done had a large bearing on the results obtained.
H. C. Purcer Smith said that an interesting point in his series was that in 6 cases during the two, three or four days before the onset of vestibular loss one got hypersensitivity indicated by caloric response. The bed-fast patients stood tests very well without undue subjective reaction. The tests were performed according to a standardized and reliable technique using cool air. In his series it was rare to find the hearing affected by chemotherapy except for one or two cases of high tone loss in young children. The monochord was an excellent instrument where the detection of high tone loss in these young people was important. The preliminary hypersensitivity before the onset of the vestibular palsy pointed to a central loss,' and the impression gained from labyrinth tests at the Manchester Royal Infirmary was that the pathological changes occurred centrally and not in the end organ. J. A. B. Thoma in reply: It is suggested by the 2 cases examined twelve months after cessation of streptomycin therapy, that the absence of response to galvanic stimulation is a much later phenomenon than the loss of caloric reaction.
The Clinical Aspects of the Streptomycin Treatment of Pulmonary Tuberculosis By J. R. BIGNALL, M.A., M.D., M.R.C.P.
Institute of Diseases of the Chest, Brompton Hospital THE treatment of pulmonary tuberculosis with streptomycin is dominated by the phenomenon of bacterial resistance. The ease with which resistant strains of tubercle bacilli emerge during prolonged treatment has considerably reduced the therapeutic effect of the antibiotic and prevented its wider use.
It has been discovered that the process of the replacement of streptomycin sensitive by resistant bacilli can be to a large extent prevented by treating the patient simultaneously ' The dissociation from hearing loss again pointed to central loss.
